Related Experiment Video
Updated: Jul 3, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Hyperkinetic manifestations in sporadic parkinsonism: An exploratory case series with APOE and NOS3 variants
Sara Varanese1, Rossella Ferrante2, Maria Pia Buongarzone1
1Neurology Clinic, San Pio Hospital Via de Lellis, 66054 Vasto, Italy.
Abstract:
Background Hyperkinetic motor features are uncommon in Parkinson's disease and related parkinsonisms and may reflect underlying genetic susceptibility. Methods We describe three sporadic patients with parkinsonism and prominent hyperkinetic manifestations who underwent clinical exome sequencing. To provide preliminary context for these observations, we reviewed genetic data from an additional cohort of 11 patients with sporadic parkinsonism who underwent clinical exome sequencing in our center but did not exhibit early hyperkinetic manifestations Results All patients carried heterozygous variants in genes involved in vascular, inflammatory, and tau related pathways (NOS3 c.774 T > C; APOE c.388 T > C). Clinical phenotypes ranged from late-onset parkinsonism with severe choreic dyskinesias to young-onset dystonic parkinsonism with excellent dopaminergic responsiveness. Dopaminergic dysfunction was supported by functional neuroimaging. Conclusions These cases suggest that APOE and NOS3 variants may act as susceptibility modifiers, predisposing to hyperkinetic phenotypes within the parkinsonian spectrum.
More Related Videos
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll
Neural Regulation